Published in Contraception on August 01, 1973
Induction of sex hormone binding globulin by phenytoin. Br Med J (1977) 2.13
Progesterone levels in peripheral plasma during the luteal phase of the normal human menstrual cycle measured by a rapid competitive protein binding technique. Acta Endocrinol (Copenh) (1969) 1.75
A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density. Maturitas (1995) 1.67
Depression of the progesterone levels in women treated with synthetic gestagens after ovulation. Acta Endocrinol (Copenh) (1971) 1.57
The effect of various dosages of lynestrenol on the plasma levels of oestrogens and progesterone during the menstrual cycle in the rhesus monkey. Contraception (1976) 1.47
Plasma levels of progesterone after vaginal, rectal, or intramuscular administration of progesterone. Am J Obstet Gynecol (1971) 1.38
Native breeds demonstrate high contributions to the molecular variation in northern European sheep. Mol Ecol (2005) 1.34
Recurrent abdominal pains as the first symptom of a spinal cord tumor. Acta Paediatr Scand (1981) 1.23
Bone loss in relation to menopause: a prospective study during 16 years. Bone (2001) 1.14
Radioimmunoassay of oestrone and oestradiol in human and bovine peripheral plasma. Acta Endocrinol (Copenh) (1972) 1.12
Relationship between the plasma levels of luteinizing hormone and progesterone during the normal menstrual cycle. J Clin Endocrinol Metab (1967) 1.09
Plasma levels of medroxyprogesterone acetate (MPA), sex-hormone binding globulin, gonadal steroids, gonadotrophins and prolactin in women during long-term use of depo-MPA (Depo-Provera) as a contraceptive agent. Acta Endocrinol (Copenh) (1982) 1.04
Practice and patterns of estrogen treatment in climacteric women in a Swedish population. A descriptive epidemiological study. Part I. Acta Obstet Gynecol Scand (1983) 1.02
Medroxyprogesterone acetate, estradiol, FSH and LH in peripheral blood after intramuscular administration of Depo-ProveraR to women. Contraception (1976) 1.01
Progesterone level and response to oxytocin at term. Lancet (1968) 1.00
A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density. Maturitas (2009) 0.99
Unfolding of population structure in Baltic sheep breeds using microsatellite analysis. Heredity (Edinb) (2005) 0.97
Plasma levels of nonconjugated oestrone, oestradiol-17beta and oestriol during uncomplicated pregnancy. Acta Obstet Gynecol Scand Suppl (1974) 0.97
Effects of continuous daily administration of 0.03 mg of d-norgestrel on the plasma levels of progesterone and the urinary excretion of oestrogens. Acta Endocrinol (Copenh) (1971) 0.96
Periovulatory progesterone concentration in the peripheral plasma of the rhesus monkey with a methodologic note on the detection of ovulation. Endocrinology (1968) 0.95
Serum concentrations of estrone, androstenedione, testosterone and sex-hormone-binding globulin in postmenopausal women with breast cancer and in age-matched controls. Ups J Med Sci (1979) 0.95
17-beta-oestradiol and the fibrinolytic activity on vein walls. J Obstet Gynaecol Br Commonw (1974) 0.94
Luteinizing hormone (LH) and progesterone in plasma and LH and oestrogens in urine during 42 normal menstrual cycles. Acta Endocrinol (Copenh) (1971) 0.93
Oral contraceptives after intestinal bypass operations. JAMA (1976) 0.93
Plasma levels of progesterone in pregnancy measured by a rapid competitive protein binding technique. Acta Endocrinol (Copenh) (1969) 0.92
Sex hormone binding globulin: the carrier protein for d-norgestrel. J Clin Endocrinol Metab (1976) 0.92
Effect of oral 17-beta-oestradiol on the liver in women with intrahepatic cholestasis (hepatosis) during previous pregnancy. Br J Obstet Gynaecol (1976) 0.91
The risk of endometrial neoplasia and treatment with estrogens and estrogen-progestogen combinations. First results of a cohort study after one to four completed years of observation. Acta Obstet Gynecol Scand (1986) 0.90
Effects of estrogen replacement therapy on abdominal fat compartments as related to glucose and lipid metabolism in early postmenopausal women. Horm Metab Res (2002) 0.90
Menstruation span--a time-limited risk factor for endometrial carcinoma. Acta Obstet Gynecol Scand (1986) 0.90
Influence of suckling and of suckling followed by TRH or LH-RH on plasma prolactin, TSH, GH and FSH. Acta Endocrinol (Copenh) (1976) 0.89
Radioimmunological methods for the estimation of oestrone, oestradiol-17beta and oestriol in pregnancy plasma. Acta Obstet Gynecol Scand Suppl (1974) 0.89
Human uterine endometrium and endometriotic tissue transplanted into nude mice. Morphologic effects of various steroid hormones. Am J Pathol (1985) 0.88
A prospective long-term study in women from pre-menopause to post-menopause: changing profiles of gonadotrophins, oestrogens and androgens. Maturitas (1986) 0.88
Gonadal steroids, gonadotropins and endometrial histology in postmenopausal women with malignant ovarian tumors. Acta Obstet Gynecol Scand (1986) 0.88
Monophasic basal body temperature in ovulatory menstrual cycles. Am J Obstet Gynecol (1972) 0.87
A simplified procedure for the assay of progesterone. Acta Endocrinol Suppl (Copenh) (1970) 0.86
Lack of clinical contraceptive efficacy of large doses of r 2323 given before implantation or after a missed period. Contraception (1975) 0.86
The influence of conjugated estrogens in radioimmunoassays using different antibodies against estradiol-17beta. Steroids (1973) 0.86
Experience with depo-medroxyprogesterone acetate (Depo-Provera) as a contraceptive agent. Acta Obstet Gynecol Scand (1972) 0.85
Clinical trial of a new oral contraceptive pill containing the natural oestrogen 17 beta-oestradiol. Br J Obstet Gynaecol (1979) 0.85
Characteristics of estrogen-treated women. A descriptive epidemiological study of a Swedish population. Part II. Acta Obstet Gynecol Scand (1983) 0.85
Serum FSH, LH and oestrone levels in postmenopausal patients on oestrogen therapy. Br J Obstet Gynaecol (1978) 0.84
The influence of norethisterone oenanthate on ovarian function. Acta Endocrinol (Copenh) (1976) 0.84
Short-term effects of danazol on endometrial histology. Acta Obstet Gynecol Scand Suppl (1984) 0.83
Effects on sex hormone binding globulin of different oral contraceptives containing norethisterone and lynestrenol. Br J Obstet Gynaecol (1980) 0.83
Patterns of circulating progesterone concentrations during the fertile menstrual cycle and the remainder of gestation in the rhesus monkey. Endocrinology (1969) 0.83
Effect of oral contraceptives on the liver in women with recurrent cholestasis (hepatosis) during previous pregnancies. J Obstet Gynaecol Br Commonw (1972) 0.83
Observations on the antigenicity and clinical effects of a candidate antipregnancy vaccine: beta-subunit of human chorionic gonadotropin linked to tetanus toxoid. Fertil Steril (1980) 0.83
Plasma levels of d-norgestrel, estradiol and progesterone during treatment with silastic implants containing d-norgestrel. Contraception (1976) 0.82
A D-norgestrel-releasing IUD. Contraception (1976) 0.82
Basal and LRH-stimulated secretion of FSH during early pregnancy. Am J Obstet Gynecol (1977) 0.82
Transfer of estradiol to human milk. Am J Obstet Gynecol (1978) 0.82
Serum estrogens and androgens in women with endometrial carcinoma. Gynecol Oncol (1986) 0.81
Human endometrium transplanted into nude mice. Histologic effects of various steroid hormones. Am J Pathol (1985) 0.81
Ovarian function during use of a levonorgestrel-releasing IUD. Contraception (1990) 0.81
Endometrial histology and circulating levels of medroxyprogesterone acetate (MPA), estradiol, FSH and LH in women with MPA induced amenorrhoea compared with women with secondary amenorrhoea. Acta Obstet Gynecol Scand (1977) 0.81
Periovulatory levels of plasma progesterone and luteinizing hormone in women. Acta Endocrinol (Copenh) (1969) 0.81
Peripheral plasma levels of oestrone and progesterone in pregnant cows treated with dexamethasone. Acta Endocrinol (Copenh) (1972) 0.80
Evaluation of the prognosis of threatened abortion from the peripheral plasma levels of progesterone, estradiol, and human chorionic gonadotropin. Am J Obstet Gynecol (1973) 0.80
Premature onset of menstrual bleeding during ovulatory cycles in women with an intrauterine contraceptive device. Am J Obstet Gynecol (1973) 0.80
Clearance of levonorgestrel from the circulation following removal of NORPLANT subdermal implants. Contraception (1988) 0.79
Peripheral plasma levels of oestrogens and progesterone during late bovine pregnancy. Acta Endocrinol (Copenh) (1973) 0.79
Sialic acid content and sperm penetration of cervical mucus in relation to total urinary oestrogen excretion and plasma progesterone levels in ovulatory women. Acta Endocrinol (Copenh) (1969) 0.79
Peripheral plasma levels of 17 -hydroxyprogesterone, progesterone and oestradiol during normal menstrual cycles in women. Acta Endocrinol (Copenh) (1972) 0.79
Levonorgestrel plasma levels during continuous administration with different models of subdermal implants. Contraception (1983) 0.79
The sterile menstrual cycle. The driving force behind pathology in the reproductive organs. Acta Obstet Gynecol Scand Suppl (1984) 0.79
Plasma levels of levonorgestrel in women during longterm use of norplant. Contraception (1981) 0.79
Plasma levels of progesterone and oestrogens in women treated with an oral contraceptive of low oestrogen content (Ovostat 1375). Acta Obstet Gynecol Scand (1975) 0.79
Decreasing serum levels of sex hormone-binding globulin around the menopause and temporary relation to changing levels of ovarian steroids, as demonstrated in a longitudinal study. Fertil Steril (1989) 0.79
Influence of hypophysectomy, sham hypophysectomy and other surgical procedures on luteal function in the rhesus monkey. Endocrinology (1968) 0.79
Plasma levels of levonorgestrel and free levonorgestrel index in women using NORPLANT implants or two covered rods (NORPLANT-2). Contraception (1987) 0.78
Blood plasma levels of progesterone and oestradiol in the dog during the oestrous cycle and pregnancy. Acta Endocrinol (Copenh) (1975) 0.78
Relation between sex hormone binding globulin and D-norgestrel levels in plasma. Acta Endocrinol (Copenh) (1977) 0.78
Levels of progesterone in peripheral plasma during the menstrual cycle of the rhesus monkey. Endocrinology (1967) 0.78
Plasma levels of oestrone, oestradiol and gonadotrophins in postmenopausal women after oral and vaginal administration of conjugated equine oestrogens (Premarin). Br J Obstet Gynaecol (1978) 0.78
Pharmacokinetic observations on medroxyprogesterone acetate administered orally and intravaginally. Contraception (1976) 0.78
Effect of HCG on plasma levels of estrogens and progesterone during the luteal phase of the menstrual cycle in rhesus monkeys (Macaca mulatta). Stimulation of sex steroid production in Rhesus monkeys. Int J Fertil (1974) 0.78
Plasma levels of d-norgestrel and ovarian function in women using intravaginal rings impregnated with dl-norgestrel for several cycles. Contraception (1976) 0.78
Studies on the gonadotropin response after administration of LH/FSH-releasing hormone (LRH) during pregnancy and after therapeutic abortion in the second trimester. Am J Obstet Gynecol (1976) 0.78
Endocrine changes before and after the menarche. I. Urinary excretion of estrogen, FSH and LH, and serum levels of progesterone, FSH and LH. Acta Obstet Gynecol Scand (1974) 0.78
A detailed analysis of menstrual blood loss in women using Norplant and Nestorone progestogen-only contraceptive implants or vaginal rings. Contraception (2000) 0.78
Plasma levels of norethindrone after single oral dose administration of norethindrone and lynestrenol. Clin Endocrinol (Oxf) (1979) 0.78
Contraception with NORPLANT implants and NORPLANT-2 implants (two covered rods). Results from a comparative clinical study in Sweden. Contraception (1988) 0.78
Plasma levels of medroxyprogesterone acetate (MPA), estradiol and progesterone in the rhesus monkey after intramuscular adminstration of Depo-Provera. Contraception (1976) 0.78
Absorption of an oral contraceptive gestagen in ulcerative colitis before and after proctocolectomy and construction of a continent ileostomy. Contraception (1985) 0.78
Assessment of placental function in uncomplicated and complicated late pregnancy by estimation of unconjugated oestrogens in plasma after an intravenous injection of dehydroepiandrosterone sulphate. Acta Endocrinol (Copenh) (1978) 0.77
Progesterone levels in amniotic fluid and plasma from women. I. Levels during normal pregnancy. Acta Obstet Gynecol Scand (1971) 0.77
Fibrinolytic activity of veins during use of depot medroxyprogesterone acetate as a contraceptive. Fertil Steril (1972) 0.77
Treatment of primary amenorrhoea with human pituitary and chorionic gonadotrophins. J Obstet Gynaecol Br Commonw (1970) 0.77
The natural oestrogenic hormone oestradiol as a new component of combined oral contraceptives. Br Med J (1977) 0.77
Medroxyprogesterone acetate pharmacokinetics following oral high-dose administration in humans: a bioavailability evaluation of a new MPA tablet formulation. Acta Pharmacol Toxicol (Copenh) (1986) 0.77
Ethinyl estradiol in human milk and plasma after oral administration. Contraception (1978) 0.76
Bioavailability of oestriol. Acta Endocrinol (Copenh) (1982) 0.76
Peripheral plasma levels of oestrogens, progesterone and 17alpha-hydroxyprogesterone during gestation in the rhesus monkey. Acta Endocrinol (Copenh) (1973) 0.76
Peripheral plasma levels of oestrone, oestradiol-17beta and progesterone during ovulatory menstrual cycles in the rhesus monkey with special reference to the onset of menstruation. Acta Endocrinol (Copenh) (1973) 0.76
Medroxyprogesterone acetate (MPA) plasma levels after oral and intramuscular administration in a long-term study. Acta Obstet Gynecol Scand Suppl (1981) 0.76
The plasma concentration of medroxyprogesterone acetate and ovarian function during treatment with medroxyprogesterone acetate in 5 and 10 mg doses. Acta Obstet Gynecol Scand (1984) 0.76